Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 2Leukemia 2Relapsed Pediatric Solid Tumor 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Mastocytosis, Systemic 1Lymphoma, T-Cell, Peripheral 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Gastrointestinal Stromal Tumors 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Imatinib Mesylate 6Laparoscopy 3Surgical Procedures, Operative 2spartalizumab 1ripretinib 1regorafenib 1ponatinib 1famitinib 1apixaban 1anlotinib 1Thoracic Surgery, Video-Assisted 1TH 302 1Surveys and Questionnaires 1Surgical Tape 1Sunitinib 1Rivaroxaban 1Oxaliplatin 1Nivolumab 1Liver Transplantation 1Ipilimumab 1Interviews as Topic 1Endoscopic Mucosal Resection 1Dasatinib 1Dalteparin 1Blood Specimen Collection 1Biopsy 168Ga-NOTA-RM26 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Stromal Tumors × Dasatinib × Clear all
NCT02776878 2016-05-18

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Peking University Cancer Hospital & Institute

Phase NA Unknown
57 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡